Statistics from Altmetric.com
A year has passed since we have joined the new editorial team of BMJ Evidence-Based Medicine (EBM), a journal initially launched in 1995. Since then, great editors have maintained a platform for EBM enthusiasts and advocates. First commentaries and then EBM verdicts critically summarised the latest evidence with important implications for clinical practice. During the last 4 years, the journal incorporated original research and other articles that aimed to promote debate and analysis of the current controversies related to evidence.
For this new phase, we invited an international editorial team considering geographical, gender, ethnic, seniority and other forms of diversity. Most of our editors, including the Editor-in-Chief, are not native English-speakers. Considering the existing barriers and inequalities in publishing for authors, we advocate and engage in minimising conscious and unconscious biases, this being part of this larger endeavour towards justice, equality, diversity and inclusion by the BMJ.1
At the end of a very remarkable 2021, facing the beginning of 2022 puts several challenges at stake: …
Twitter @dwan_kerry, @MarleenKunneman, @mintimetz, @nicolasmezac, @dnunan79, @Richards_G_C, @paula_riganti, @AVeroniki
Contributors All authors wrote, revised and approved this manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.